Yes, dollars outgoing is six times revenue and less than 1 quarter of funding in the bank. The expected government rebate will see the quarter out, but yet more working capital is required and it has to be raised within twelve weeks. The company has not yet reached a stage where debt funding is a responsible option, nor is a buy-in or takeover likely when the company is still so far from commercial operation, so there is no reasonable alternative to issuing shares.
I wonder how much of the R&D burn is due to chasing FDA approval. I will also be interested to see over time how much revenue the company can produce with the infant app.
Add to My Watchlist
What is My Watchlist?
